Evaluation of Valvular Heart Disease Using Cardiac CT
Evaluation of Valvular Heart Disease: Multicenter Registry of Noninvasive Imaging Modalities by Cardiac CT
Toho University
350 participants
Mar 12, 2025
OBSERVATIONAL
Conditions
Summary
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis. 1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.
Eligibility
Inclusion Criteria2
- Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
- years of age or older
Exclusion Criteria5
- Less than 18 years old
- Acute VHD
- Infectious endocarditis
- Patients with post-VHD intervention
- Poor CT image quality for analyzing CT data.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06937125